MedTrace Logo

Caffein Consumption and Response Inhibition

NCT01815203 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 21

Last updated 2013-09-25

No results posted yet for this study

Summary

With the abundance of energy-dense foods that are designed for ease of consumption in the current environment, it is of importance to better understand the factors that may undermine the control of energy intake at healthy levels.

One of the factors that is potentially important in response inhibition is caffeine.

The aim is to assess the direct effects of caffeine on response inhibition, using a No Go/Go-task. We will also assess whether the presentation of food cues, i.e. as words or as pictures, modulate response inhibition different in restrained vs. non-restrained eaters.

Conditions

Interventions

DRUG

Caffeine

Administration of one gelatin capsule containing 200-300 mg of caffeine with subsequent cognitive tasks and food test.

DRUG

Placebo

Administration of placebo with subsequent cognitive tasks and food test.

Sponsors & Collaborators

  • Uppsala University

    lead OTHER

Principal Investigators

  • Pleunie Hogenkamp, PhD · Uppsala University

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
SINGLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
35 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2013-03-31
Primary Completion
2013-07-31
Completion
2013-08-31

Countries

  • Sweden

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01815203 on ClinicalTrials.gov